Poly Medicure Limited has scheduled a one-on-one meeting with analysts and investors for September 24, 2026. The company disclosed the engagement as part of its ongoing investor relations activities.

The session will be held at the company's registered office in New Delhi. Officials from Poly Medicure will participate in the discussion with representatives from ICICI Securities PMS.

Meeting Details

The interaction is set to begin at 4:00 pm on Thursday, September 24, 2026. The venue is located at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110 020.

Regulatory Disclosure

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that no unpublished price-sensitive information would be shared during the meeting.

Avinash Chandra, Company Secretary, signed the disclosure dated September 21, 2026. The schedule remains subject to change due to exigencies involving the analysts, investors, or the company.

Poly Medicure Limited announced a scheduled one-on-one investor meeting with Axis Max Life for September 23, 2026. The virtual session is set for 4:00 pm, providing a platform for direct engagement between the company's officials and the investor.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A. This regulatory framework mandates timely disclosure of material events and interactions with analysts or investors to ensure market transparency.

Meeting Details

The company confirmed that no unpublished price-sensitive information will be shared during the interaction. The schedule remains subject to change due to exigencies on the part of the analysts, investors, or the company itself.

Avinash Chandra, Company Secretary, signed the intimation filed with both the BSE and NSE listing departments. The full details are also available on the company's official website.